FDA Hikes Fees for Your Pet's Generic Meds in 2026
Published Date: 7/30/2025
Notice
Summary
The FDA is setting the fees and payment rules for companies making generic animal drugs in fiscal year 2026. If you create or sponsor these generic animal medicines, expect some updated costs and deadlines to keep your products moving. These changes help the FDA keep things running smoothly and on time for safer, affordable animal meds.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
FY2026 Generic Animal Drug User Fees
If you make or sponsor generic animal drugs, the FDA is setting new user fee rates and payment procedures for fiscal year 2026. The fees apply to certain abbreviated new animal drug applications, certain generic new animal drug products, sponsors of those applications and investigational submissions for generic new animal drugs (JINADs), and related submissions.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in